Freka PEG Gastric Feeding Tube

CH/FR 9

• ENFit Connector
• Fine lumen, gastric 
• Length: 30cm
• External diameter: 2.9mm
• Internal diameter: 1.9mm

CH/FR 15

• ENFit connector
• Wide lumen, gastric 
• Length: 35cm
• External diameter: 4.8mm
• Internal diameter: 3.6mm 

CH/FR 20

• ENFit connector 
• Wide lumen, gastric
• Length: 35cm
• Exteral diameter: 6.6mm
• Internal diameter: 5.0mm

• Polyurethane tube with radio-opaque strip and silicone disc
• Radio-opaque retention disc made from silicone
• Puncture cannula with safety (air) valve 
• Introducer cone with double thread 
• Scalpel 
• External colour and size coded fixation plate (silicone) for securing tube (CH 9, white/yellow. CH 15, blue. CH 20 purple)
• ENFit connector
• Interval markings every 2cm (from 2cm-16cm)
• Tube clamp 
• Latex, PVC, DEHP free 

Freka^® PEG set gastric for enteral use only.

Long-term intragastric feeding in patients with inadequate oral nutrition intake (<60% of the calculated energy supply) and the need for nutritional feeding for a period exceeding 2-3 weeks:

• to avoid further loss of body weight
• to correct significant nutritional deficiencies 
• to rehydrate the patient
• to promote the growth in children with growth retardation
• improve the quality of life due to adequate nutritional intake 

Palliative gastric decompression/drainage by gravity

• In the presence of a chronic gastrointestinal stenosis or ilus 

The PEG FR 15 can be used for application of an intestinal tube as a guide tube.

Use of a wide-lumen gastric PEG (PEG FR 20) is particularly recommended for:

• administration of high-viscosity tube feed nutrition
• decompression and drainage of viscous fluid
• frequent drug administration (also with specific  galenics)
• use of the gastric port for instrument insertion for therapeutic/diagnostic purposespositioning of an intestinal tube for gastric decompression and intestinal feeding

There is an increased risk of peritonitis in:

• severe cachexia
• multiple diseases and poor general condition
• clearly limited expectation of life or
• with long-standing diabetes

There is a risk of fistula formation in:

• Crohn’s disease

Contraindications

• Lack of transillumination and positive needle aspiration test
• Interposed organs
• Serious coagulation disorders
• Marked peritoneal carcinomatosis
• Severe ascites 
• Peritonitis
• Anorexia nervosa
• Serious psychosis
• Patients in terminal stage
• Severe erosive gastritis/ulcer
• Tumour infiltration at puncture site 

Freka PEG can be placed endoscopically into the jejunum (EPJ) - refer to manufacturers guidance for further details.